The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Soros - from the RNS Results from the study will be used in the design of the next phase of clinical trials for CogniCann®, including defining the appropriate End Points and patient sample size.